Wells Fargo Downgrades Allergan to Equal-Weight, Announces $198 Price Target
Wells Fargo analyst David Maris downgrades Allergan (NYSE:AGN) from Overweight to Equal-Weight and announces $198 price target.
Credit Suisse Downgrades Yiren Digital to Underperform
Credit Suisse analyst Yirendai Zhong downgrades Yiren Digital (NYSE:YRD) from Neutral to Underperform.
DA Davidson Initiates Coverage On SciPlay with Buy Rating
DA Davidson analyst Franco Granda initiates coverage on SciPlay (NASDAQ:SCPL) with a Buy rating.
Credit Suisse Downgrades Qudian to Neutral
Credit Suisse analyst Charles Zhou downgrades Qudian (NYSE:QD) from Outperform to Neutral.
Stifel Nicolaus Downgrades Lilis Energy to Hold
Stifel Nicolaus analyst Michael Scialla downgrades Lilis Energy (AMEX:LLEX) from Buy to Hold.
Goldman Sachs Upgrades Coca-Cola Femsa to Buy
Goldman Sachs analyst Luca Cipiccia upgrades Coca-Cola Femsa (NYSE:KOF) from Neutral to Buy.
Citigroup Downgrades Estee Lauder Cos to Neutral, Raises Price Target to $230
Citigroup analyst Wendy Nicholson downgrades Estee Lauder Cos (NYSE:EL) from Buy to Neutral and raises the price target…
JMP Securities Initiates Coverage On Cue Biopharma with Market Outperform Rating, Announces $22 Price Target
JMP Securities analyst Reni Benjamin initiates coverage on Cue Biopharma (NASDAQ:CUE) with a Market Outperform rating and a…
Morgan Stanley Initiates Coverage On ACM Research with Overweight Rating, Announces $45 Price Target
Morgan Stanley initiates coverage on ACM Research (NASDAQ:ACMR) with a Overweight rating and a $45 price target.
Needham Upgrades NeoPhotonics to Buy, Announces $11 Price Target
Needham analyst Alex Henderson upgrades NeoPhotonics (NYSE:NPTN) from Hold to Buy and announces $11 price target.